Align Technology (ALGN) Wins European Patent Infringement Ruling Against Angelalign
gurufocus.com · 2026-10-18
On October 18, 2026, Align Technology Inc (NASDAQ: ALGN) announced a favorable ruling from the Unified Patent Court in Paris, which found that Angelalign's Torq
TickrTrends take: Align Technology's European patent victory against competitor Angelalign strengthens its intellectual property moat in a key market, which typically supports pricing power and market position for Healthcare sector companies. Since TickrTrends currently assesses ALGN as undervalued, investors monitoring this patent ruling should consider how successful enforcement of proprietary technology might affect the company's competitive advantages and long-term revenue sustainability. Patent wins can reduce competitive pressure and protect market share, factors that valuation models incorporate when reassessing a company's growth trajectory and defensive characteristics.
Read the full story at gurufocus.com →
Is ALGN undervalued? See TickrTrends' fair value analysis →